|
Charles A. Sanders, M.D. Dr. Sanders is the former chairman and CEO of Glaxo Inc., as well as a former member of the board of Glaxo plc. Before joining Glaxo Inc., Dr. Sanders spent eight years with Squibb Corp. where he held a number of posts including the position of vice chairman. He also served as chief executive officer of the science and technology group and chairman of the science and technology committee of Squibb’s Board. Prior to this, Dr. Sanders was general director of Massachusetts General Hospital and professor of medicine at Harvard Medical School. A native of Dallas, he is a graduate of Southwestern Medical College of the University of Texas. Dr. Sanders is past chairman of the New York Academy of Sciences, past chairman of The Commonwealth Fund, and past chairman of the Overseers Committee to Visit the Harvard Medical School. He is currently a member of the Institute of Medicine of the National Academy of Sciences, a member of the CSIS Board of Trustees, chairman of Project HOPE, and chairman of the Foundation for the National Institutes of Health. In addition, he serves on the boards of Genentech, Vertex Pharmaceuticals, BioPure, Trimeris, Cephalon, and Fisher Scientific International. In the past Dr. Sanders has served on the boards of several multi-national corporations, including Merrill Lynch and Company, Morton International Inc, and Reynolds Metals Company. | 